COVID-19–Related Stigma Among Inpatients With COVID-19 Infection

Moideen, Shamsudeen; Uvais, N. A.; Rajagopal, Sooraj; Maheshwari, V.; Gafoor, Tasneem Abdul; Sherief, Sheik Haja

doi:10.4088/pcc.20br02853

Cited by 8 publications

(15 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were 16 studies from Africa [ 14 , 24 , 59 , 68 – 73 , 75 – 79 , 84 , 88 ], 25 studies from Asia [ 22 , 60 , 61 , 64 – 66 , 74 , 80 , 81 , 83 , 86 , 87 , 90 – 95 , 97 – 99 , 101 , 102 , 104 , 105 ], and others were conducted in Europe [ 67 , 89 , 96 ], North America [ 62 , 63 , 85 , 100 , 103 ] and South America [ 82 ]. More than half (27 studies) of the studies were conducted within community populations [ 22 , 60 , 66 , 69 – 72 , 74 , 76 , 79 – 81 , 83 , 85 – 88 , 90 , 91 , 93 , 95 , 99 – 104 ], while others consisted of health care workers (13 studies) [ 60 , 61 , 63 , 64 , 67 , 77 , 78 , 84 , 89 , 92 , 94 , 96 , 105 ] and patients (eight studies) [ 14 , …”

Section: Resultsmentioning

confidence: 99%

“…More than half (27 studies) of the studies were conducted within community populations [ 22 , 60 , 66 , 69 – 72 , 74 , 76 , 79 – 81 , 83 , 85 – 88 , 90 , 91 , 93 , 95 , 99 – 104 ], while others consisted of health care workers (13 studies) [ 60 , 61 , 63 , 64 , 67 , 77 , 78 , 84 , 89 , 92 , 94 , 96 , 105 ] and patients (eight studies) [ 14 , 24 , 59 , 68 , 73 , 75 , 97 , 98 ]. Of the 50 articles, 10 studies [ 24 , 59 , 73 , 75 , 80 , 82 , 85 , 91 , 97 , 105 ] used modified scales for measuring stigma, while other studies measured the stigma by using one or more questions [ 14 , 22 , 60 – 72 , 74 , 76 – 79 , 81 , 83 , 84 , 86 – 90 , 92 – 96 , 98 – 104 ] (Table 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…3 and S5 ). In terms of the education level of participants, as twenty studies [ 14 , 61 , 63 – 65 , 68 – 70 , 72 , 73 , 77 , 84 , 89 , 92 , 94 , 97 , 99 , 100 , 102 , 105 ] did not report educational levels or did not indicate tertiary education proportion, 30 studies were included in this subgroup analysis. We divided the studies into two groups according to the proportion of participants with tertiary education (<50% and ≥50%).…”

Section: Resultsmentioning

confidence: 99%

“…First, the lack of reliable and valid instruments of infectious disease-related stigma used in the populations studied is a major limitation for both research and practice. Only 10 studies [ 24 , 59 , 73 , 75 , 80 , 82 , 85 , 91 , 97 , 105 ] used modified scales for measuring stigma. And these measure tools, such as the Ebola-related stigma Questionnaire, seven-item EVD-related stigma index, varied widely in terms of measurement development, the groups surveyed and the domains assessed (i.e., knowledge, attitude, and behavior).…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action

et al. 2021

View full text Add to dashboard Cite

Infectious diseases, including COVID-19, are crucial public health issues and may lead to considerable fear among the general public and stigmatization of, and discrimination against, specific populations. This meta-analysis aimed to estimate the pooled prevalence of stigma in infectious disease epidemics. We systematically searched PubMed, PsycINFO, Embase, MEDLINE, Web of Science, and Cochrane databases since inception to June 08, 2021, and reported the prevalence of stigma towards people with infectious diseases including SARS, H1N1, MERS, Zika, Ebola, and COVID-19. A total of 50 eligible articles were included that contributed 51 estimates of prevalence in 92722 participants. The overall pooled prevalence of stigma across all populations was 34% [95% CI: 28−40%], including enacted stigma (36% [95% CI: 28−44%]) and perceived stigma (31% [95% CI: 22−40%]). The prevalence of stigma in patients, community population, and health care workers, was 38% [95% CI: 12− 65%], 36% [95% CI: 28−45%], and 30% [95% CI: 20−40%], respectively. The prevalence of stigma in participants from low- and middle-income countries was 37% [95% CI: 29−45%], which is higher than that from high-income countries (27% [95% CI: 18−36%]) though this difference was not statistically significant. A similar trend of prevalence of stigma was also observed in individuals with lower education (47% [95% CI: 23−71%]) compared to higher education level (33% [95% CI: 23−4%]). These findings indicate that stigma is a significant public health concern, and effective and comprehensive interventions are needed to counteract the damaging effects of the infodemics during infectious disease epidemics, including COVID-19, and reduce infectious disease-related stigma.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The 12‐items short version showed satisfactory construct validity and reliability comparing to psychometric properties of the full‐length scale (Cronbach's α for the subscales were all >0.7) 15 . This questionnaire was widely used as screening tool for stigma in previous infectious outbreaks as well as in this current pandemic 9,10,16,17 . Thus, we used this short version with its four subscales intended to evaluate concerns with public attitudes, personalized stigma, negative self‐image, and disclosure concerns 15 .…”

Section: Methodsmentioning

confidence: 99%

Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study

Mlouki

Zammit

Ghammam

et al. 2022

Health Science Reports

View full text Add to dashboard Cite

Background and Aim The COVID‐19 is a stigmatizing infectious disease even after healing. Until now, no COVID‐19 stigma scale validated in Tunisian Arabic language among the general population is available. Developing such tools is necessary to detect COVID‐19 stigma and reduce it effectively. Indeed, stigmatization of COVID‐19 patients could increase the spread of this disease and its related mental health issues. We aimed at testing the validity of a translated and modified version of the 12‐item HIV stigma scale among Tunisian COVID‐19 patients. Methods A cross‐sectional study was conducted between November and December 2020 among a representative sample of COVID‐19 patients in the governorate of Sousse, Tunisia, after quarantine. The 12‐item HIV stigma scale was translated in Tunisian Arabic and then modified to be adapted to the Tunisian context. The preliminary modified version was administrated to the participants by pretrained medical doctors during phone calls. It consisted on 20 items covering the four stigma dimensions (personalized stigma, disclosure concerns, concerns with public attitudes, and negative self‐image). The psychometric evaluation of this version included internal consistency as well as principal component analysis (PCA). Results The responses of 346 COVID‐19 patients were obtained. Their median age was 40 years (interquartile range: 30‐54.5). Females represented 60.4% of them. The PCA resulted in a three factor solution with 14 items. This 14‐item scale demonstrated good internal consistency with a global Cronbach's α of 0.91 and values of 0.94, 0.93, and 0.98 for social stigma, negative self‐image, and disclosure concerns, respectively. Conclusion This study provides a reliable and valid instrument for stigma measuring among Tunisian COVID‐19 patients. The use of this scale would contribute in reducing the spread of this new infectious disease and its related mental health issues.

show abstract

Stigma Mechanisms in a Globalized Pandemic in India: A Theoretical Framework for Stigma

Chatterjee

Ramraj

2023

Global Perspectives of COVID-19 Pandemic on Health, Education, and Role of Media

View full text Add to dashboard Cite

Stigma has been documented to act as a significant barrier to healthcare access and healthcare-seeking behavior. Traditional frameworks of stigma and discrimination have been used in the past to explain the stigma associated with diseases such as tuberculosis, leprosy, and HIV. However, increasing globalization and unprecedented access to information via social media and the internet have altered infectious disease dynamics and have forced a rethink on mechanisms which propagate stigma. SARS, MERS, Ebola, and more recently COVID-19 have been associated with fear in communities across the globe due to the inherent uncertainties associated with emerging infectious diseases and a concurrent spread of misinformation—an infodemic. The authors present a theoretical framework to explain the evolution of COVID-19 associated stigma by exploring the complex interplay of various international and national mechanisms. It is anticipated that a conceptual framework which explains the evolution of stigma in fast-spreading global pandemics such as COVID-19 may also prove to be useful as a starting point for furthering the discussion on the progenitors, pathways, and manifestations of COVID-19-related stigma. This should be of practical use to researchers who are interested in exploring, validating, and identifying interventions for informing other frameworks for similar diseases.

show abstract

COVID-19–Related Stigma Among Inpatients With COVID-19 Infection

Cited by 8 publications

References 0 publications

A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action

A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action

Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study

Stigma Mechanisms in a Globalized Pandemic in India: A Theoretical Framework for Stigma

Contact Info

Product

Resources

About